Three ULiège projects selected for Welbio Investigator Program funding
As part of the Welbio Investigator Program call for projects, two FARAH projects and one GIGA project were selected for funding at the Université de Liège.
As a public university open to the world and is anchored in the scientific, cultural and economic development of its region, the University of Liège relies on its three pillars: teaching, research and civic engagement.
ULiège trains responsible citizens who are provided with cutting-edge knowledge and critical thinking, are able to share knowledge and can push forward an increasingly complex world.
ULiège develops and promotes excellence in research, multidisciplinary and direct engagement with its instruction.
Global exposure is a top priority at the University of Liège. The institution offers a wide range of international mobility opportunities to students, researchers and staff, enabling them to enhance their cross-disciplinary skills and language knowledge.
ULiège: an experience of daily living. Located in 3 cities and 4 campuses, the university is a key player in terms of the environment and mobility.
The University of Liège (ULiège) announces that it has developed an automated test for the detection of SARS-CoV-2, the virus responsible for Covid-19. The technique developed at ULiège allows to increase the daily capacity of detection of the coronavirus in Liège by 2000 tests. ULiège thus becomes one of the 5 reference centres for the detection of SARS-CoV-2. The technique could quickly be adopted by the 4 other reference centres (GSK, UCB, Janssen Pharmaceutica and KULeuven), as well as by other countries.
T
he test can detect carriers of the virus, whether they are sick or asymptomatic carriers. It is an automated test, less dependent on reagents at risk of shortage and requiring a reduced number of operators.
It is based on three successive steps that provide a reliable result in half a day.
1st step: inactivation of the virus.
The material in the sample tube (swab) is brought into contact with chemicals and enzymes. This step aims to inactivate the virus while preserving some of its components (genetic material), so that it can be detected in the subsequent procedure. This operation must be carried out in high-security laboratories of L2 or L3 type.
2nd step: extraction of the virus.
The SARS-CoV-2 is an RNA virus; i.e. its genome does not contain DNA. This step aims to extract the viral RNA. Current extraction methods are either manual, requiring time and a large number of operators, or automated, relying on the use of reagents whose supply is no longer guaranteed. It is this step that was limiting and significantly hindered the performance of screening tests. Researchers from GIGA, FARAH, GreenMat/CESAM of ULiège and the University Hospital (CHU) of Liège joined forces to make this step faster, automated and independent of commercial reagents.
3rd step: conversion of RNA to DNA, and DNA amplification
After the RNA is extracted, it is converted into DNA, which is then amplified a large number of times in order to be detectable. This step uses the qRT-PCR technique. The RNA is first transcribed (RT) to DNA using an enzyme (reverse transcriptase) and then amplified by quantitative (q) PCR (polymerase chain reaction). By using this method, the genesis of each copy of the SARS-CoV-2 viral RNA is associated with the emission of fluorescence, ultimately confirming whether the sample is positive or negative.
With the exception of the inactivation step 1, which requires a larger number of people taking turns in the L2 and L3 laboratories, the other two steps require the simultaneous presence of only 4 people.
This automated, rapid and reliable technique for the detection of sick or asymptomatic carriers of the virus allows the ULiège team to carry out 2000 tests per day. The laboratories that have developed this method are now backed up by the clinical microbiology laboratory of the CHU of Liège for the performance of local tests, but will also be involved in mass screening, starting with systematic screening in rest homes where there are many people at risk.
The development of this technique is a major step towards providing Belgium, and potentially other countries, with the significant testing capacity necessary to manage the Covid-19 health crisis.
Via the Communication - Press Department of the University of Liège
+32 (0)494 57 25 30 - dmoreau@uliege.be
Illustration : Fusion medical animation for Unsplash
As part of the Welbio Investigator Program call for projects, two FARAH projects and one GIGA project were selected for funding at the Université de Liège.
A "Sit-in liège students in solidarity for Palestine" is currently taking place at the University of Liège, on the Place du 20 août campus.
The seven partners of the Université de la Grande Région met at the Château de Colonster (ULiege campus) to take stock of current collaborations and outline the future of the consortium.